1. Proactive Authorization Initiation

Initiating authorizations as soon as possible increases the likelihood of timely treatment starts for patients. While early authorization may not always be possible, we recommend beginning the process at least three to five days in advance. This proactive approach helps manage your team’s workload more efficiently while enhancing the patient experience. Our data shows that many large commercial insurers can take anywhere from three to seven business days to process chemotherapy authorizations—and sometimes even longer for other services—making early planning critical.

2. Mid-Cycle Authorization Reviews

Insurance rules and patient coverage can change frequently throughout the year. We conduct comprehensive mid-cycle authorization reviews to re-verify financial clearance for each treatment cycle. Our tracking systems document and monitor existing authorizations to flag when extensions or new approvals are needed. This proactive strategy significantly reduces the risk of authorization denials due to expired authorizations, insurance changes, or modifications in treatment plans.

3. Denial Monitoring and Trend Analysis

To minimize the impact of authorization delays, we track and analyze authorization denials by drug and insurer. By identifying and documenting trends—such as varying turnaround times and frequent rescheduling of patients due to delayed authorizations—we provide data-driven insights to escalate and address issues with payers as needed. This approach ensures that your practice can respond strategically to shifting insurance policies, reducing disruptions in patient care.